about
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cyclingSteroid hormone receptors: evolution, ligands, and molecular basis of biologic function.Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging.Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrenceTranscription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.Vitamin D: marker or mechanism of action?Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its componentsSentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signalingVitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells.Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles.Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasiaThe role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axisAssociations between circulating 1,25(OH)₂D concentration and odds of metachronous colorectal adenomaFGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes.CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma RecurrencePhysical activity, sedentary behavior, and vitamin D metabolitesCYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells.Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.Modeling, synthesis, and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydroVitamin D receptor-mediated control of Soggy, Wise, and Hairless gene expression in keratinocytes.Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells.Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.Molecular mechanisms of vitamin D action.Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.Examination of the potential functional role of conserved cysteine residues in the hormone binding domain of the human 1,25-dihydroxyvitamin D3 receptor.Retinoid X Receptor Selective Agonists and their Synthetic Methods.Resveratrol potentiates vitamin D and nuclear receptor signaling.Greater Adherence to Cancer Prevention Guidelines Is Associated with Higher Circulating Concentrations of Vitamin D Metabolites in a Cross-Sectional Analysis of Pooled Participants from 2 Chemoprevention Trials.Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter.1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.Purified human vitamin D receptor overexpressed in E. coli and baculovirus systems does not bind 1,25-dihydroxyvitamin D3 hormone efficiently unless supplemented with a rat liver nuclear extract.Phosphorylation of the human 1,25-dihydroxyvitamin D3 receptor by cAMP-dependent protein kinase, in vitro, and in transfected COS-7 cells.The vitamin D hormone and its nuclear receptor: molecular actions and disease states.The vitamin D-responsive element in the rat bone Gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3- mediated transcriptional activation.The nuclear vitamin D receptor: biological and molecular regulatory properties revealed.
P50
Q26766256-C8A2C32C-E2C6-4163-8D75-2D27358D5932Q28572351-3E31C154-3357-4FC1-9AC4-3AB50F0A4FDBQ28572560-BEE951AE-1D80-4280-A714-A9A9CDABEFBCQ33813420-60448483-5641-4B90-A73C-BDFBFA6B994CQ33940141-E06F87D9-0014-4A53-B736-6962F2DAF951Q34005255-0F5A03BD-F1CE-44C4-BBB8-C23F5B9C563FQ34483364-FB14F02C-EB2C-4C74-83B7-B2E2FC6A2EF7Q34629724-43F5F312-CA1D-4715-8840-E593748C7723Q34779662-61D5DCC2-9A6B-4504-A62E-16FC97A97EA7Q34779961-3B57D27A-B8BF-4F0E-9F2C-6A7178693795Q35033693-9C207A3A-BC92-4BDF-9474-79719077D0DAQ35107487-AB7AB7F0-8DE2-4112-8FAE-9B88D3CC3DACQ35532076-25A4A393-D9C0-4287-9594-D3DDAD19E3E1Q35664947-C109FAFB-4E12-4875-B3FF-74CF858C84D5Q35745287-7A06C53A-08F6-4E4A-8BE3-64DA9AE2BC78Q35784205-8824DB4C-68A5-4468-902A-1D500D67D9C7Q35955537-A56F0DF8-E035-4E4F-9F26-8E0446E5E9AAQ36028456-95C3DBA0-23E1-4309-83B1-A9DFA268A637Q36109141-A72E0A72-0827-46D7-A690-75C259F4373FQ36695024-6C7334A5-1E8A-4616-858F-00DF142F9AD4Q36778121-55CE24E2-BF1A-47CF-B844-732A3BC7692BQ37290310-2A8BC28E-F73D-4CA8-BA2D-64409CF9FC6EQ37562445-6E06E3C2-7796-4C04-94FD-92FEBCC4CF95Q37626156-790139AB-8F28-4EE6-BAD1-612F9D691EA4Q37684545-44E54073-72A5-419A-8C27-601669F1964CQ37923110-94428630-D76C-4C6F-B79B-05689D1DD872Q38025329-26472E9A-BAE1-4EF4-9C67-FFD904FA2670Q38333559-D58D4468-C4AC-4434-9CCD-F87634AF48A0Q38361181-E6DF61EB-33EF-409A-829F-786C1364953FQ38869968-F7E8E860-63D8-47B0-9BF7-819D21F078CBQ38925813-6F376E7C-09A8-48CF-BDAA-42ADB958EE9EQ38998966-F5542D21-0833-4D16-BE5A-D98EF6365884Q40001200-BE74D649-F00D-46E4-B4BE-43CCDC206A2DQ40018179-84DE3DC1-62BA-46B2-AAD8-BA68D10A2C8FQ40172351-0D6DFEB4-87BA-498C-A1D8-EADB38BF97AEQ41508525-88801A29-435D-4673-8B93-4238339A8DA5Q41565071-57FE8C3E-0BAF-4382-BBC8-509E3B95D8DBQ41649611-99E4C39C-1A9D-45DC-95C8-182E845BF794Q41694470-161A6518-2D7A-49F0-B015-4C04FBBD112DQ41731155-9265D30A-F471-429B-9D3F-CADBDDEE36E9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter W Jurutka
@nl
Peter W Jurutka
@sl
Peter W. Jurutka
@en
Peter W. Jurutka
@es
type
label
Peter W Jurutka
@nl
Peter W Jurutka
@sl
Peter W. Jurutka
@en
Peter W. Jurutka
@es
prefLabel
Peter W Jurutka
@nl
Peter W Jurutka
@sl
Peter W. Jurutka
@en
Peter W. Jurutka
@es
P106
P1153
6603818619
P21
P31
P496
0000-0002-4950-9161